Experimental activities supporting commercial U.S. accelerator production of 99-Mo
- Los Alamos National Laboratory
- ANL
{sup 99m}Tc, the daughter product of {sup 99}Mo, is the most commonly used radioisotope for nuclear medicine in the U.S. Experiments are being performed at Los Alamos National Laboratory and Argonne National Laboratory to demonstrate production of {sup 99}Mo using accelerators. The {sup 100}Mo({gamma},n){sup 99}Mo reaction in an enriched {sup 100}Mo target is currently under investigation. Three scaled low-power production experiments using a 20-MeV electron linac at Argonne have been performed to date. Two of these experiments used natural Mo targets and produced a total of 613 {mu}C of {sup 99}Mo. The third experiment used an enriched {sup 100}Mo target and produced 10.5 mCi of {sup 99}Mo. Following irradiation the targets were dissolved and the low specific activity solution was processed through an ARSII generator from NorthStar Medical Radioisotopes. Yields of {sup 99m}Tc >95% have been observed.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC52-06NA25396
- OSTI ID:
- 1028197
- Report Number(s):
- LA-UR-10-05589; LA-UR-10-5589; TRN: US1105552
- Resource Relation:
- Conference: 2010 Conference on the Application of Accelerators in Research and Industry ; August 13, 2010 ; Ft. Worth, TX
- Country of Publication:
- United States
- Language:
- English
Similar Records
Recovery and Recycle of Irradiated Low-Enriched Uranium from the Production of 99Mo
Small Punch Testing of Molybdenum-99 Targets